Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). Antidepressiva: Wissenschaftliche Neubewertung der SSRI / SNRI abgeschlossen – Neue Warnhinweise auf suizidales Verhalten bei Kindern und Jugendlichen. 2005.
Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN). S3-Leitlinie Zwangsstörungen. AWMF-Registernr.: 038-017. 2022.
Dos Santos-Ribeiro S, de Menezes GB, Moreira-de-Oliveira ME et al. The effect of treatment on the quality of life of patients with obsessive-compulsive disorder: systematic review and meta-analysis. J Psychiatr Res 2025; 188: 19-28.
Ivarsson T, Skarphedinsson G, Kornør H et al. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis. Psychiatry Res 2015; 227(1): 93-103.
Joseph JT, Vishwanath R, Praharaj SK. Efficacy and safety of accelerated transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and meta-analysis. Asian J Psychiatr 2025; 106: 104420.
Kotapati VP, Khan AM, Dar S et al. The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis. Front Psychiatry 2019; 10: 523.
Li K, Qian L, Zhang C et al. Deep transcranial magnetic stimulation for treatment-resistant obsessive-compulsive disorder: A meta-analysis of randomized-controlled trials. J Psychiatr Res 2024; 180: 96-102.
Locher C, Koechlin H, Zion SR et al. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis. JAMA Psychiatry 2017; 74(10): 1011-1020.
Romanelli RJ, Wu FM, Gamba R et al. Behavioral Therapy and Serotonin Reuptake Inhibitor Pharmacotherapy in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis of Head-to-Head Randomized Controlled Trials. Depress Anxiety 2014; 31(8): 641-652.
Skapinakis P, Caldwell D, Hollingworth W et al. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults. Health Technol Assess 2016; 20(43): 1-392.
Skarphedinsson G, Hanssen-Bauer K, Kornør H et al. Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a systematic review of effect estimates across comparisons. Nord J Psychiatry 2015; 69(2): 81-92.
Steele DW, Kanaan G, Caputo EL et al. Treatment of Obsessive-Compulsive Disorder in Children and Youth: A Meta-Analysis. Pediatrics 2024 [Epub ahead of print].
Wang Y, Miguel C, Ciharova M et al. The effectiveness of psychological treatments for obsessive-compulsive disorders: a meta-analysis of randomized controlled trials published over last 30 years. Psychol Med 2024; 54(11): 2838-2851.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.